Every lot published · search any lot number before you order

Retatrutide 12 mg: Phase 2 and TRIUMPH-1 Results

The 12 mg Phase 2 arm had an estimated mean weight reduction of 24.2% at 48 weeks. The sponsor’s TRIUMPH-1 efficacy analysis reported a 28.3% mean reduction at 80 weeks in its 12 mg arm.

Retatrutide 12 mg: Phase 2 and TRIUMPH-1 Results. Two studies and two time points. Assigned amount, Trial protocol, Group result. GLP LIFE SCIENCES · RESEARCH BRIEF 26 Two studies and two time points Dosage research Assigned amountTrial protocolGroup result
Two studies and two time points. Illustration for this research brief.

Two studies and two time points

Both estimates compare groups assigned within their own protocols. The longer duration and differences in the study populations and analysis affect the interpretation.

How to interpret the evidence

Read each result next to its placebo value and time point. Neither percentage gives a personal expected response.

This series reports assigned research arms for interpreting study results. Retatrutide is investigational, and clinical-trial amounts are not dosing instructions.

Sources